Најди сличен содржај

💊🇺🇸FDA APPROVES BREAKTHROUGH DRUGS FOR RARE DISEASES 🔹 Yuviwel approved Feb 27 for dwarfism growth — first-ever treatment for kids 👶 🔹 Loargys gets green light for ultra-rare Arginase 1 Deficiency 🧬 🔹 Bysanti breakthrough schizophrenia drug hits market February 20th 🧠 🔹 Wellcovorin approved March 10 for cerebral folate deficiency 🧪 🔹 Takeda's narcolepsy drug oveporexton submits for late March review 😴 5 novel drug approvals in first quarter — fastest pace since 2023! 📈 Rare disease patients get hope as FDA accelerates orphan drug pipeline... 🙏✨ #FDA#MedicalBreakthrough#RareDiseases#DrugApproval @america